MMSI vs SGHT
MMSI: Merit Medical provides a broad range of proprietary medical devices used globally in minimally invasive interventional and diagnostic procedures. SGHT: Sight Sciences develops minimally invasive interventional devices for glaucoma and dry eye, targeting ophthalmology markets through reimbursement-focused commercialization.
Side-by-side fundamentals
| Metric | MMSI | SGHT | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $85.01 | $5.26 | |
| Market cap as of 2026-08-03 | $5.1B | $286M | |
| P/E as of 2026-08-03 | 35.04 | n/a | |
| PEG as of 2026-08-03 | 4.04 | n/a | |
| Net margin as of 2026-08-03 | +9.2% | -46.8% | MMSI higher |
| Gross margin as of 2026-08-03 | +49.5% | +86.9% | SGHT higher |
| Operating margin as of 2026-08-03 | +12.8% | -44.8% | MMSI higher |
| ROE as of 2026-08-03 | +9.1% | -59.1% | MMSI higher |
| ROA as of 2026-08-03 | +5.3% | -32.2% | MMSI higher |
| Debt / equity as of 2026-08-03 | 0.44 | 0.75 | MMSI lower |
| Revenue growth (YoY) as of 2026-08-03 | +10.2% | +1.9% | MMSI higher |
| Revenue CAGR (3y) SEC XBRL | +9.6% | +2.7% | MMSI higher |
| Beta as of 2026-08-03 | 0.72 | 1.59 | |
| 1-year return as of 2026-07-31 close | +0.2% | +58.0% | SGHT higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.